Impact of NMT1 Gene Polymorphisms on Features of the Metabolic Syndrome among Severely Obese Patients

Authors:
  • MVMarie-Claude Vohl
    Marie-Claude Vohl
Open Access
Publisher website
Google Scholar
Abstract
Introduction: N-myristoyltransferase (NMT) is implicated in myristoylation, required for biological activities of several proteins. Its gene N-myristoyltransferase 1 (NMT1) has been foundto be overexpressed and hypermethylated in Visceral Adipose Tissue (VAT) of severely obeseindividuals with Metabolic Syndrome (MetS+) versus without (MetS-).Objective: The aim of this study was to verify the associations between NMT1 gene polymorphisms Single Nucleotide Polymorphisms (SNPs) and metabolic complications among obesesubjects.Methods: Associations between SNPs and determinants of MetS were tested with 1752 obeseparticipants undergoing a bariatric surgery. The effect of selected SNPs on methylation, andcorrelation with expression levels of NMT1 were verified in subgroups.Results: Rs2239921 was significantly associated with systolic (p=0.03) and diastolic (p<0.0001)blood pressures. Rs2239923 was associated with plasma High Density Lipoprotein-Cholesterolor HDL-Cholesterol (HDL-C) levels (p=0.05), while rs2269746 was associated with Low Density Lipoprotein-Cholesterol or LDL-Cholesterol (LDL-C) (p=0.006) and Total-Cholesterol(Total-C) levels (p=0.004). Rs1005136 (p=0.03), rs8066395 (p=0.03) or rs2157840 (p=0.04)were associated with plasma concentrations of C-Reactive Protein (CRP). Phenotype-associated SNPs were associated with NMT1 methylation levels of six CpG sites. NMT1 methylationlevels of one CpG site, cg10755730, correlated with gene expression levels (r=0.57; p=0.04).Conclusion: These results suggest that the presence of NMT1 SNPs is associated with alteredplasma lipid levels as well as with increased inflammation markers and blood pressure amongseverely obese patients.

This publication has 37 references indexed in Scilit: